AKER

Akers Biosciences (AKER)

Akers Biosciences Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:AKER

<< 前へ 1 2 3 4 5 6 7 8 9 10 11 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2022/10/27	06 : 20	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:AKER	Akers Biosciences Inc
2022/10/27	06 : 18	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:AKER	Akers Biosciences Inc
2022/09/20	21 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AKER	Akers Biosciences Inc
2022/09/09	05 : 23	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:AKER	Akers Biosciences Inc
2022/08/30	21 : 00	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	NASDAQ:AKER	Akers Biosciences Inc
2022/08/18	06 : 19	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AKER	Akers Biosciences Inc
2022/08/18	04 : 01	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:AKER	Akers Biosciences Inc
2022/08/15	21 : 32	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:AKER	Akers Biosciences Inc
2022/08/04	05 : 32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AKER	Akers Biosciences Inc
2022/07/27	05 : 32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AKER	Akers Biosciences Inc
2022/07/06	05 : 41	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:AKER	Akers Biosciences Inc
2022/06/21	23 : 30	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AKER	Akers Biosciences Inc
2022/05/17	07 : 19	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:AKER	Akers Biosciences Inc
2022/04/13	21 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AKER	Akers Biosciences Inc
2022/04/01	06 : 19	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:AKER	Akers Biosciences Inc
2022/02/24	06 : 52	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:AKER	Akers Biosciences Inc
2022/02/24	02 : 03	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AKER	Akers Biosciences Inc
2022/02/08	23 : 21	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AKER	Akers Biosciences Inc
2022/01/12	06 : 31	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:AKER	Akers Biosciences Inc
2022/01/05	23 : 29	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AKER	Akers Biosciences Inc
2021/12/30	07 : 29	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AKER	Akers Biosciences Inc
2021/12/04	06 : 32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AKER	Akers Biosciences Inc
2021/11/30	02 : 46	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AKER	Akers Biosciences Inc
2021/11/25	02 : 56	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AKER	Akers Biosciences Inc
2021/11/23	07 : 28	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:AKER	Akers Biosciences Inc
2021/11/16	23 : 26	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AKER	Akers Biosciences Inc
2021/11/16	06 : 54	Edgar (US Regulatory)	Amended Quarterly Report (10-q/a)	NASDAQ:AKER	Akers Biosciences Inc
2021/11/13	07 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AKER	Akers Biosciences Inc
2021/10/16	06 : 24	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AKER	Akers Biosciences Inc
2021/10/16	06 : 22	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AKER	Akers Biosciences Inc